FLORIDA FINANCIAL ADVISORS, LLC

Position in EXEL — Exelixis, Inc.

CIK 2050972 TAMPA, FL

Position in EXEL

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$225,583

New position

Shares Held

4,146

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#567

of 751 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

FLORIDA FINANCIAL ADVISORS, LLC holds $4,238,695 across 4 Biotechnology names. EXEL ranks #3 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	54,314	$3,045,385
2	RVMD	Revolution Medicines, Inc.	4,833	$905,124
3	EXEL	Exelixis, Inc. This page	4,146	$225,583
4	CMPX	Compass Therapeutics, Inc.	28,586	$62,603

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$225,583	4,146	—	Shares	Sole	2026-08-10
No filing history on record for this holder in this stock.